Literature DB >> 2163551

Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies.

H Ishii1, M Nakano, J Tsubouchi, T Ishikawa, H Uchiyama, S Hiraishi, C Tahara, Y Miyajima, M Kazama.   

Abstract

Thrombomodulin, TM, is an endothelial cell membrane protein acting as a cofactor for the activation of plasma protein C. Soluble TM is present in plasma and urine of normal subjects. Enzyme immunoassay, EIA, for human TM was developed using mouse monoclonal antibodies against human placental TM in this paper. We obtained four types of the monoclonal antibodies against human placental TM. EIA sandwich method using three types of the monoclonal antibodies enabled us to measure almost all of 6 and 7 TM subspecies in plasma and urine, respectively, except 1 subspecies, 31 kDa TM. There was no interference from other components of plasma and urine in the assay conditions. Titration curves of purified TM in buffer or in normal plasma were linear within the range from 0.08 to 10 ng/ml. The coefficient of variation at 0.08 ng/ml TM was 4.7%. TM titer with buffer, assayed by this method, was reduced by the addition of thrombin at the final concentration of 20 U/ml, but the titer with plasma was not reduced even at 100 U/ml. These concentrations of thrombin are far larger than those which would be formed in circulation. TM levels in plasma and urine of normal subjects collected in the morning were 35.2 +/- 8.32 ng/ml (n = 346) and 111 +/- 31.6 ng/ml (n = 33), respectively. TM level in plasma did not differ from the level in serum. Circadian fluctuation of plasma TM was not significant in 10 normal adults, although a tendency of increase in TM excretion to urine was found rather in the day time than the other times.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163551

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Clinical application of endothelial injury marker in hypertensive patients.

Authors:  Xiao Qian Guo; Wei Ren; Rui Peng; Yan Hong Liu; Yan Li
Journal:  J Clin Lab Anal       Date:  2018-03-24       Impact factor: 2.352

3.  False negative results of anticardiolipin antibody test.

Authors:  S Kobayashi; M Tanaka; H Tsuda; H Hashimoto; S Hirose; T Saikawa; K Yoshida
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

4.  Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals.

Authors:  Michael W J Boehme; Peter Galle; Wolfgang Stremmel
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

5.  Victims of lethal hypothermia have decreased levels of thrombomodulin in myocardium and urine.

Authors:  Lasse Pakanen; Helena Kaija; Marja-Leena Kortelainen; Terttu Särkioja; Katja Porvari
Journal:  Int J Legal Med       Date:  2014-12-28       Impact factor: 2.686

6.  Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.

Authors:  M W Boehme; Y Deng; U Raeth; A Bierhaus; R Ziegler; W Stremmel; P P Nawroth
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

7.  Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.

Authors:  M Maruno; T Yoshimine; T Isaka; R Kuroda; H Ishii; T Hayakawa
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP.

Authors:  S Horie; K Kizaki; H Ishii; M Kazama
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

9.  Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin.

Authors:  S Horie; H Ishii; H Hara; M Kazama
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  Altered expression of antithrombotic molecules in human glioma vessels.

Authors:  T Isaka; T Yoshimine; M Maruno; R Kuroda; H Ishii; T Hayakawa
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.